Johannes Schwarz

发表

Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study

Alexander Gerhard, Johannes Schwarz, Ralph Myers, 2005, NeuroImage.

Detection of brain shift in functional neurosurgery by deformation field analysis

Gero Strauß, Johannes Schwarz, Jürgen Meixensberger, 2004, CARS.

Towards Design Elements to Represent Business Models for Cyber Physical Systems

Christine Legner, Johannes Schwarz, Nicola Terrenghi, 2018, ECIS.

Method and apparatus for controlling geopositionsbasierten-delayed systems

Johannes Schwarz, Christian Deilmann, Michael Münnix, 2012 .

MicroTargeting® platform: an individual stereotaxic device in functional neurosurgery

Gero Strauß, Johannes Schwarz, Jürgen Meixensberger, 2006, International Journal of Computer Assisted Radiology and Surgery.

Towards comparable business model concepts: resource description framework (RDF) schemas for semantic business model representations

Christine Legner, Johannes Schwarz, Nicola Terrenghi, 2017 .

From One to Many Business Models: Uncovering characteristics of Business Model Portfolios

Christine Legner, Johannes Schwarz, Nicola Terrenghi, 2017, ECIS.

Association between reduced Alpha4Beta2 nicotinic acetylcholine receptor availability and nonmotor symptoms in early drug naive Parkinson disease

Johannes Schwarz, Swen Hesse, Marianne Patt, 2010, NeuroImage.

Analytics As A Service: Cloud Computing and the Transformation of Business Analytics Business Models and Ecosystems

Christine Legner, Johannes Schwarz, Dana Naous, 2017, ECIS.

Business Model Management: Current Practices, Required Activities and IT Support

Christine Legner, Johannes Schwarz, Nicola Terrenghi, 2017, Wirtschaftsinformatik.

Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease.

Johannes Schwarz, Swen Hesse, Marianne Patt, 2009, Archives of general psychiatry.

Comparison of T2*-weighted and QSM contrasts in Parkinson's disease to visualize the STN with MRI

Johannes Schwarz, Andreas Schäfer, Gilles de Hollander, 2017, PloS one.

Expression of mutant &agr;-synucleins enhances dopamine transporter-mediated MPP+ toxicity in vitro

Johannes Schwarz, Alexander Storch, A. Storch, 2002, Neuroreport.

Monoamine transporter availability in Parkinson’s disease patients with or without depression

Johannes Schwarz, Swen Hesse, Philipp M. Meyer, 2009, European Journal of Nuclear Medicine and Molecular Imaging.

High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias.

Johannes Schwarz, Alexander Storch, Christian Oehlwein, 2005, Parkinsonism & related disorders.

Glutamate receptor properties of human mesencephalic neural progenitor cells: NMDA enhances dopaminergic neurogenesis in vitro

Johannes Schwarz, Wolfgang Härtig, Florian Wegner, 2009, Journal of neurochemistry.

Nicotinic acetylcholine receptors in patients with Parkinson's disease and Alzheimer's disease: Specific binding of 2-[18F]F-A-85380 in the cerebral white matter as demonstrated by PET and comparison with diffusion tensor MRI (DTI)

Johannes Schwarz, Swen Hesse, Florian Then Bergh, 2005 .

A Humanized Version of Foxp2 Affects Cortico-Basal Ganglia Circuits in Mice

Johannes Schwarz, Julia Fischer, Valérie Gailus-Durner, 2009, Cell.

Susceptibility Mapping of the Substantia Nigra in Parkinson Patients at 7T after One Year of Diagnosis and Treatment

Sonja A. Kotz, Johannes Schwarz, Robert Turner, 2010 .

1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism

Johannes Schwarz, Alexander Storch, A. Storch, 2000, Brain Research.

Mesodermal cell types induce neurogenesis from adult human hippocampal progenitor cells

Johannes Schwarz, Holger Lerche, Stefan Liebau, 2006, Journal of neurochemistry.

D2 Dopamine Receptors Colocalize Regulator of G-Protein Signaling 9-2 (RGS9-2) via the RGS9 DEP Domain, and RGS9 Knock-Out Mice Develop Dyskinesias Associated with Dopamine Pathways

Johannes Schwarz, Melvin I Simon, H. Lester, 2005, The Journal of Neuroscience.

RGS9 Modulates Dopamine Signaling in the Basal Ganglia

Johannes Schwarz, David Self, Robert R Luedtke, 2003, Neuron.

Neurorestoration in Parkinson’s disease by cell replacement and endogenous regeneration

Johannes Schwarz, Alexander Storch, M. Gerlach, 2004, Expert opinion on biological therapy.

Low atmospheric oxygen avoids maturation, senescence and cell death of murine mesencephalic neural precursors

Johannes Schwarz, Alexander Storch, Knut Krohn, 2005, Journal of neurochemistry.

Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter.

Johannes Schwarz, Alexander Storch, Rainer Ortmann, 2002, Biochemical pharmacology.

Long-Term Proliferation and Dopaminergic Differentiation of Human Mesencephalic Neural Precursor Cells

Johannes Schwarz, Andreas Kupsch, Alexander Storch, 2001, Experimental Neurology.

Psychosis pathways converge via D2High dopamine receptors

Johannes Schwarz, Kazuhiko Yanai, Tomiki Sumiyoshi, 2006, Synapse.

Steele‐Richardson‐Olszewski‐Syndrome: Reduction of dopamine D2 receptor binding relates to the severity of midbrain atrophy in vivo: 123IBZM SPECT and MRI study

Johannes Schwarz, Wolfgang H Oertel, Klaus Tatsch, 2002, Movement disorders : official journal of the Movement Disorder Society.

An ERP study of vocal emotion processing in asymmetric Parkinson's disease.

Johannes Schwarz, Silke Paulmann, Sonja A Kotz, 2013, Social cognitive and affective neuroscience.

Transcription Profiling of Adult and Fetal Human Neuroprogenitors Identifies Divergent Paths to Maintain the Neuroprogenitor Cell State

Johannes Schwarz, Holger Lerche, Alexander Storch, 2007, Stem cells.